STOCK TITAN

Iron Dome Acquisition I faces Nov. 18, 2027 deal deadline

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Iron Dome Acquisition I Corp. (IDAC) reported net income of $1,087,694 for the quarter ended September 30, 2026, as $1,408,474 of income earned on cash in trust exceeded $320,780 of formation and operating expenses. For the nine months, net income was $1,716,907, including $2,065,245 of trust income; the company has not generated operating revenue.

At September 30, 2026, the trust held $159,850,245, while cash outside the trust was $649,173. The company is pursuing a business combination and said it will cease operations and liquidate if it does not complete one by November 18, 2027. Management said the mandatory liquidation raises substantial doubt about its ability to continue as a going concern.

Management identified a material weakness in accounting for complex financial instruments, specifically the Public Warrants’ initial fair value, and concluded disclosure controls were ineffective as of September 30, 2026. It revised the prior warrant valuation, determining the error was not material to previously issued financial statements.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major pointMaterial weakness left disclosure controls ineffective as of September 30, 2026.
  • Major point. Forward-looking: it has not happened yet and may not happen.Potential liquidation by November 18, 2027 raises substantial doubt about going concern.

Filing Explained

If exercised, the 10.6 million outstanding warrants would add 10.6 million Class A shares and reduce current holders’ ownership percentages.

This 10-Q reports that, as of September 30, 2026, the company had not completed a business combination; 15.7 million public shares can be redeemed for a pro rata portion of trust funds in a combination or liquidation, so those funds remain subject to the public-share redemption mechanism.

As of that date, 10.6 million warrants were outstanding: 7.85 million public and 2.75 million private, with each whole warrant exercisable for one Class A share at $11.50.

The warrants become exercisable only after the later of a business combination and 12 months from the IPO closing, and only if the share issuance is registered or exempt; if exercised, they would add shares and reduce existing holders’ percentage ownership.

Completion of a business combination would also trigger payment of $9.42 million in deferred underwriting and advisory fees and $690,136 in deferred service-provider fees.

Quarterly net income $1,087,694 Three months ended September 30, 2026
Quarterly trust income $1,408,474 Three months ended September 30, 2026
Quarterly formation and operating expenses $320,780 Three months ended September 30, 2026
Cash held in trust $159,850,245 As of September 30, 2026
Cash outside trust $649,173 As of September 30, 2026
Total liabilities $10,111,836 As of September 30, 2026
Deferred underwriting commission and advisory fees $9,420,000 Presented on the balance sheet as of September 30, 2026
Revised Public Warrant fair value $1,422,185 Initial fair value measurement; revised from $3,164,821
going concern financial
"raises substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
material weakness technical
"a material weakness in our internal control over financial reporting"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
initial fair value measurement financial
"error in the initial fair value measurement of the Public Warrants"
deferred underwriting commission financial
"total of $9,420,000 of deferred underwriting commission and advisory fees"
Class A ordinary shares subject to possible redemption financial
"Class A ordinary shares subject to possible redemption as of September 30, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did IDAC revise its Public Warrant valuation?

The initial Public Warrant fair value was revised from $3,164,821 to $1,422,185. Management said the error was not material to the previously issued financial statements and had no impact on total assets, total liabilities, Class A ordinary shares subject to possible redemption, total shareholders’ deficit, net income or cash flows.

What happens if IDAC does not complete a business combination by November 18, 2027?

If IDAC does not complete a business combination by November 18, 2027, it will cease operations except to wind up and redeem 100% of outstanding Public Shares as promptly as reasonably possible, but no more than ten business days thereafter. The redemption price is based on the trust account balance, including interest not previously released for permitted withdrawals, less up to $100,000 of interest for dissolution expenses. The warrants will expire worthless.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0002090441 false --12-31 Q3 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember 00-0000000 0002090441 2026-07-01 2026-09-30 0002090441 2026-01-01 2026-09-30 0002090441 us-gaap:WarrantMember 2026-01-01 2026-09-30 0002090441 idac:PublicWarrantsMember 2026-01-01 2026-09-30 0002090441 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:OverAllotmentOptionMember 2026-05-18 0002090441 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:OverAllotmentOptionMember 2026-05-18 0002090441 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:OverAllotmentOptionMember 2026-05-18 0002090441 us-gaap:MeasurementInputExpectedTermMember us-gaap:OverAllotmentOptionMember 2026-05-18 0002090441 us-gaap:MeasurementInputOptionVolatilityMember 2026-05-18 0002090441 idac:MeasurementInputProbabilityOfAnInitialBusinessCombinationMember 2026-05-18 0002090441 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-05-18 0002090441 us-gaap:MeasurementInputExpectedDividendRateMember 2026-05-18 0002090441 us-gaap:MeasurementInputExpectedTermMember 2026-05-18 0002090441 idac:PrivatePlacementWarrantsMember 2026-01-01 2026-09-30 0002090441 us-gaap:CommonClassAMember 2026-01-01 2026-09-30 0002090441 us-gaap:CommonClassAMember idac:BusinessCombinationMember 2026-09-30 0002090441 idac:PublicWarrantMember 2026-09-30 0002090441 idac:PublicWarrantMember 2026-01-01 2026-09-30 0002090441 us-gaap:CommonClassAMember idac:PublicWarrantMember 2026-01-01 2026-09-30 0002090441 2026-09-30 0002090441 us-gaap:WarrantMember 2025-12-31 0002090441 idac:PrivatePlacementWarrantsMember 2026-09-30 0002090441 idac:PublicWarrantMember us-gaap:OverAllotmentOptionMember 2026-09-30 0002090441 us-gaap:WarrantMember 2026-09-30 0002090441 us-gaap:CommonClassBMember 2026-06-29 0002090441 us-gaap:OverAllotmentOptionMember 2026-05-19 0002090441 us-gaap:CommonClassBMember 2025-12-31 0002090441 us-gaap:CommonClassBMember 2026-09-30 0002090441 us-gaap:CommonClassBMember 2026-01-01 2026-09-30 0002090441 us-gaap:CommonClassAMember 2026-09-30 0002090441 us-gaap:CommonClassAMember us-gaap:IPOMember 2026-01-01 2026-09-30 0002090441 us-gaap:IPOMember 2026-09-30 0002090441 idac:UnderwritingAgreementMember 2026-09-30 0002090441 idac:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2026-01-01 2026-09-30 0002090441 idac:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002090441 us-gaap:OverAllotmentOptionMember 2026-09-30 0002090441 us-gaap:IPOMember 2026-01-01 2026-09-30 0002090441 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassBMember 2026-06-29 2026-06-29 0002090441 us-gaap:IPOMember 2026-05-20 2026-05-20 0002090441 idac:UnderwritingAgreementMember us-gaap:IPOMember 2026-05-19 2026-05-19 0002090441 us-gaap:OverAllotmentOptionMember 2026-01-01 2026-09-30 0002090441 us-gaap:IPOMember us-gaap:RelatedPartyMember 2025-12-30 2025-12-30 0002090441 us-gaap:IPOMember us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0002090441 idac:SponsorMember 2025-12-31 0002090441 idac:SponsorMember 2025-01-01 2025-12-31 0002090441 idac:SponsorMember 2026-07-01 2026-09-30 0002090441 idac:SponsorMember 2026-01-01 2026-09-30 0002090441 idac:PostbusinessCombinationMember us-gaap:CommonClassAMember 2026-09-30 0002090441 idac:PostbusinessCombinationMember us-gaap:CommonClassAMember 2026-01-01 2026-09-30 0002090441 2025-12-31 0002090441 idac:SponsorMember 2026-09-30 0002090441 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0002090441 us-gaap:RelatedPartyMember 2026-07-01 2026-09-30 0002090441 us-gaap:CommonClassAMember idac:SponsorMember 2026-01-01 2026-09-30 0002090441 idac:FounderSharesMember 2026-01-01 2026-09-30 0002090441 us-gaap:CommonClassBMember idac:PaulHodermarksyMember 2026-01-21 2026-01-21 0002090441 us-gaap:CommonClassBMember idac:DavidDeWaltMember 2025-12-10 2025-12-10 0002090441 us-gaap:CommonClassBMember idac:EyalWaldmanMember 2025-12-02 2025-12-02 0002090441 us-gaap:CommonClassBMember srt:DirectorMember 2026-01-21 2026-01-21 0002090441 us-gaap:CommonClassBMember srt:DirectorMember 2025-12-10 2025-12-10 0002090441 us-gaap:CommonClassBMember srt:DirectorMember 2025-12-02 2025-12-02 0002090441 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember idac:SponsorMember 2026-06-29 2026-06-29 0002090441 us-gaap:OverAllotmentOptionMember 2026-05-19 2026-05-19 0002090441 idac:FounderSharesMember 2026-09-30 0002090441 us-gaap:CommonClassBMember 2026-01-26 2026-01-26 0002090441 us-gaap:CommonClassBMember 2026-06-29 2026-06-29 0002090441 us-gaap:CommonClassBMember idac:FounderSharesMember 2026-01-26 0002090441 us-gaap:CommonClassBMember 2026-05-07 2026-05-07 0002090441 us-gaap:CommonClassBMember idac:SponsorMember 2026-01-26 2026-01-26 0002090441 us-gaap:CommonClassBMember idac:FounderSharesMember 2025-09-26 2025-09-26 0002090441 idac:TrustAccountMember 2026-05-18 2026-05-18 0002090441 us-gaap:IPOMember 2026-05-18 2026-05-18 0002090441 us-gaap:PrivatePlacementMember us-gaap:CommonClassAMember 2026-05-18 0002090441 idac:PrivatePlacementWarrantsMember 2026-05-18 0002090441 us-gaap:IPOMember us-gaap:CommonClassAMember idac:PublicWarrantMember 2026-05-18 0002090441 us-gaap:IPOMember us-gaap:CommonClassAMember 2026-05-18 0002090441 us-gaap:IPOMember idac:PublicWarrantMember 2026-05-18 0002090441 us-gaap:IPOMember us-gaap:CommonClassAMember idac:PublicWarrantMember 2026-05-18 2026-05-18 0002090441 us-gaap:IPOMember 2026-05-18 0002090441 idac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-09-30 0002090441 idac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-09-30 2026-09-30 0002090441 idac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-06-30 0002090441 idac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-06-30 2026-06-30 0002090441 idac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-05-18 0002090441 idac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-05-18 2026-05-18 0002090441 idac:NonRedeemableSharesOutstandingMember 2026-01-01 2026-09-30 0002090441 idac:RedeemableSharesOutstandingMember 2026-01-01 2026-09-30 0002090441 idac:NonRedeemableSharesOutstandingMember 2026-07-01 2026-09-30 0002090441 idac:RedeemableSharesOutstandingMember 2026-07-01 2026-09-30 0002090441 idac:PublicWarrantMember 2026-09-30 0002090441 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2026-06-29 0002090441 idac:InitialBusinessCombinationMember idac:PublicSharesMember 2026-09-30 0002090441 idac:TrustAccountMember 2026-09-30 0002090441 idac:TrustAccountMember idac:PublicSharesMember 2026-09-30 0002090441 idac:PublicSharesMember 2026-01-01 2026-09-30 0002090441 idac:InitialBusinessCombinationMember us-gaap:CommonClassBMember 2026-09-30 0002090441 us-gaap:CommonClassAMember idac:InitialBusinessCombinationMember 2026-09-30 0002090441 idac:TrustAccountMember 2026-01-01 2026-09-30 0002090441 us-gaap:IPOMember idac:TrustAccountMember idac:PrivatePlacementWarrantMember 2026-09-30 0002090441 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-09-30 0002090441 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-01 2026-09-30 0002090441 us-gaap:OverAllotmentOptionMember 2026-06-29 2026-06-29 0002090441 2026-06-29 2026-06-29 0002090441 us-gaap:OverAllotmentOptionMember 2026-05-20 2026-05-20 0002090441 us-gaap:OverAllotmentOptionMember 2026-05-20 0002090441 us-gaap:OverAllotmentOptionMember 2026-05-18 2026-05-18 0002090441 idac:PrivatePlacementWarrantMember 2026-05-18 2026-05-18 0002090441 idac:PrivatePlacementWarrantMember 2026-05-18 0002090441 us-gaap:CommonClassAMember us-gaap:IPOMember 2026-05-18 2026-05-18 0002090441 2025-09-05 2025-09-30 0002090441 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2026-09-30 0002090441 2025-09-30 0002090441 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-30 0002090441 2025-09-06 2025-09-30 0002090441 us-gaap:AdditionalPaidInCapitalMember 2025-09-06 2025-09-30 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-06 2025-09-30 0002090441 us-gaap:RetainedEarningsMember 2026-09-30 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-09-30 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-09-30 0002090441 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002090441 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002090441 2026-06-30 0002090441 us-gaap:RetainedEarningsMember 2026-06-30 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-06-30 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-06-30 0002090441 2026-04-01 2026-06-30 0002090441 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002090441 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-04-01 2026-06-30 0002090441 2026-03-31 0002090441 us-gaap:RetainedEarningsMember 2026-03-31 0002090441 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0002090441 2026-01-01 2026-03-31 0002090441 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002090441 us-gaap:RetainedEarningsMember 2025-12-31 0002090441 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-31 0002090441 idac:SponsorMember 2026-06-29 2026-06-29 0002090441 us-gaap:CommonClassBMember 2026-05-07 0002090441 us-gaap:OverAllotmentOptionMember 2026-06-29 0002090441 us-gaap:CommonClassAMember 2025-12-31 0002090441 us-gaap:CommonClassBMember 2026-11-16 0002090441 us-gaap:CommonClassAMember 2026-11-16 0002090441 idac:RedeemableWarrantsIncludedAsPartOfTheUnitsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2026-01-01 2026-09-30 0002090441 idac:ClassAOrdinarySharesIncludedAsPartOfTheUnitsMember 2026-01-01 2026-09-30 0002090441 idac:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOnehalfOfOneRedeemableWarrantMember 2026-01-01 2026-09-30 0002090441 2025-01-01 2025-12-31 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002090441 idac:RedeemableSharesOutstandingMember 2025-09-05 2025-09-30 0002090441 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-07-01 2026-09-30 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002090441 idac:NonRedeemableSharesOutstandingMember 2025-09-05 2025-09-30 0002090441 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-09-05 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-05 0002090441 us-gaap:AdditionalPaidInCapitalMember 2025-09-05 0002090441 us-gaap:RetainedEarningsMember 2025-09-05 0002090441 2025-09-05 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-09-06 2025-09-30 0002090441 us-gaap:RetainedEarningsMember 2025-09-06 2025-09-30 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-09-30 0002090441 us-gaap:RetainedEarningsMember 2025-09-30 0002090441 2025-09-04 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-12-31 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-01-01 2026-03-31 0002090441 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0002090441 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002090441 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-03-31 iso4217:USD xbrli:pure idac:Segment iso4217:USD xbrli:shares xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q 

 

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the quarter ended September 30, 2026 

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the transition period from to

 

Commission file number: 001-43168 

 

Iron Dome Acquisition I Corp. 

(Exact Name of Registrant as Specified in Its Charter)

 

Cayman Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

244 Fifth Avenue, Suite #1814
New York, New York 10001
  10001
(Address of principal executive offices)   (Zip Code)

 

(410) 671-5481
(Issuer’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant   IDACU   The Nasdaq Stock Market LLC
Class A ordinary shares included as part of the units   IDAC   The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   IDACW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b - 2 of the Exchange Act). Yes ☒ No ☐

 

As of November 16, 2026 there were 15,900,000 Class A ordinary shares, $0.0001 par value and 5,300,000 Class B ordinary shares, $0.0001 par value, issued and outstanding.

 

 

 

 

 

Iron Dome Acquisition I Corp.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

    Page
Part I. Financial Information   1
Item 1. Interim Financial Statements   1
Condensed Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025   1
Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2026 and for the Period from September 5, 2025 (Inception) through September 30, 2025   2
Unaudited Condensed Statements of Changes in Shareholders’ Equity (Deficit) for the Three and Nine Months Ended September 30, 2026 and for the Period from September 5, 2025 (Inception) through September 30, 2025   3
Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2026 and for the Period from September 5, 2025 (Inception) through September 30, 2025   4
Notes to Unaudited Condensed Financial Statements   5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   20
Item 3. Quantitative and Qualitative Disclosures About Market Risk   23
Item 4. Controls and Procedures   23
Part II. Other Information   25
Item 1. Legal Proceedings   25
Item 1A. Risk Factors   25
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   25
Item 3. Defaults Upon Senior Securities   25
Item 4. Mine Safety Disclosures   26
Item 5. Other Information   26
Item 6. Exhibits   26
Signatures   27

 

i

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Interim Financial Statements.

 

IRON DOME ACQUISITION I CORP.
CONDENSED BALANCE SHEETS

 

    September 30,
2026
(unaudited)
    December 31,
2025
 
ASSETS            
Current Assets:            
Cash   $ 649,173     $ -  
Prepaid expenses     266,369       -  
Total Current Assets     915,542       -  
Cash held in Trust     159,850,245       -  
Deferred offering costs     -       695,255  
Total Assets   $ 160,765,787     $ 695,255  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)                
Current Liabilities:                
Accrued offering costs   $ -     $ 253,425  
Accounts payable     1,700       -  
Related party payable     -       86,158  
Total Current Liabilities     1,700       339,583  
Accrued offering costs - non-current     690,136       -  
Deferred underwriting commission     9,420,000       -  
Total Liabilities     10,111,836       339,583  
                 
Commitments and contingencies (Note 6)                
                 
Class A ordinary shares, $0.0001 par value; 15,700,000 shares subject to possible redemption as of September 30, 2026 at $10.18 per share, none as of December 31, 2025     159,850,245       -  
                 
Shareholders’ Equity (Deficit):                
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding     -       -  
Class A ordinary shares, $0.0001 par value, 200,000,000 shares authorized, 200,000 issued and outstanding as of September 30, 2026, none as of December 31, 2025     20       -  
Class B ordinary shares, $0.0001 par value, 15,000,000 shares authorized, 5,300,000 shares issued and
outstanding(1)(2)
    530       530  
Additional paid-in capital     -       399,470  
Accumulated deficit     (9,196,844 )     (44,328 )
Total Shareholders’ Equity (Deficit)     (9,196,294 )     355,672  
Total Liabilities and Shareholders’ Equity (Deficit)   $ 160,765,787     $ 695,255  

  

(1) On May 19, 2026, the underwriter partially exercised the over-allotment option and purchased 700,000 Units, which closed on May 20, 2026. The over-allotment option expired unexercised with respect to the remaining 1,550,000 Units on June 29, 2026, and 516,667 Class B ordinary shares held by the Sponsor were forfeited. Following such forfeiture, the Sponsor holds 5,300,000 Class B ordinary shares (see Note 6).

  

(2) Shares and associated amounts have been retroactively restated to reflect the surrender for no consideration of 1,916,666 Class B ordinary shares by the Sponsor on May 7, 2026, and the forfeiture of 516,667 Class B ordinary shares by the Sponsor on June 29, 2026.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

IRON DOME ACQUISITION I CORP.
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND FOR THE PERIOD FROM
SEPTEMBER 5, 2025 (INCEPTION) THROUGH SEPTEMBER 30, 2025

 

    For the
Three Months
Ended
September 30,
2026
    For the
Period from
September 5,
2025
(Inception)
through
September 30,
2025
    For the
Nine Months
ended
September 30,
2026
    For the
Period from
September 5,
2025
(Inception)
through
September 30,
2025
 
                         
Formation and operating expenses   $ 320,780     $       -     $ 561,161     $        -  
TOTAL EXPENSES     320,780       -       561,161       -  
                                 
OTHER INCOME                                
Income earned on cash held in Trust     1,408,474       -       2,065,245       -  
Change in fair value of overallotment option     -       -       212,823       -  
TOTAL OTHER INCOME     1,408,474       -       2,278,068       -  
                                 
Net income   $ 1,087,694     $ -     $ 1,716,907     $ -  
                                 
Weighted average of redeemable shares outstanding basic and diluted     15,700,000       -       7,761,172       -  
Basic and diluted net income per ordinary share   $ 0.07     $ -       0.25       -  
Weighted average of non-redeemable shares outstanding basic and diluted(1)     5,500,000       -       5,398,901       -  
Basic and diluted net (loss) per ordinary share   $ (0.02 )   $ -     $ (0.04 )   $ -  

 

(1) Shares and associated amounts have been retroactively restated to reflect the surrender for no consideration of 1,916,666 Class B ordinary shares by the Sponsor on May 7, 2026, and the forfeiture of 516,667 Class B ordinary shares by the Sponsor on June 29, 2026.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

IRON DOME ACQUISITION I CORP.
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN

SHAREHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND FOR THE PERIOD FROM
SEPTEMBER 5, 2025 (INCEPTION) THROUGH SEPTEMBER 30, 2025

 

    Class A
Ordinary Shares
    Class B
Ordinary Shares(2)
    Additional
Paid-In
    Accumulated     Shareholders’
Equity
 
    Shares     Amount     Shares     Amount     Capital     Deficit     (Deficit)  
Balance, December 31, 2025     -     $ -       5,300,000     $ 530     $ 399,470     $ (44,328 )   $ 355,672  
Services provided by shareholder of the Sponsor     -       -       -       -       45,000       -       45,000  
Balance, March 31, 2026     -               5,300,000       530       444,470       (44,328 )     400,672  
Over-allotment option(1)     -       -       -       -       (212,823 )     -       (212,823 )
Services provided by shareholder of the Sponsor     -       -       -       -       45,000       -       45,000  
IPO Advisor shares     200,000       20       -       -       1,999,980       -       2,000,000  
Proceeds from private placement     -       -       -       -       2,750,000       -       2,750,000  
Public warrants, fair value     -       -       -       -       1,422,185       -       1,422,185  
Offering costs allocated to private placement     -       -       -       -       (283,136 )     -       (283,136 )
Remeasurement of carrying value to redemption value at IPO close     -       -       -       -       (6,165,676 )     (8,811,678 )     (14,977,354 )
Accretion of funds in trust from interest income     -       -       -       -       -       (656,771 )     (656,771 )
Net income     -       -       -       -       -       629,213       629,213  
Balance, June 30, 2026     200,000       20       5,300,000       530       -       (8,883,564 )     (8,883,014 )
Services provided by shareholder of the Sponsor     -       -       -       -       7,500       -       7,500  
Remeasurement of Class A ordinary shares to redemption value     -       -       -       -       (7,500 )     (1,400,974 )     (1,408,474 )
Net income     -       -       -       -       -       1,087,694       1,087,694  
Balance, September 30, 2026     200,000     $ 20     $ 5,300,000     $ 530     $ -     $ (9,196,844 )   $ (9,196,294 )

 

    Class A
Ordinary Shares
    Class B
Ordinary Shares(2)
    Additional
Paid-In
    Accumulated     Shareholders’
Equity
 
    Shares     Amount     Shares     Amount     Capital     Deficit     (Deficit)  
For the period from September 5, 2025 (inception) through September 30, 2025:                                          
Balance, September 5, 2025 (inception)           -     $        -       -     $ -     $ -     $          -     $ -  
Issuance of Class B ordinary shares to Sponsor     -       -       5,300,000       530       24,470       -       25,000  
Services provided by shareholder of the Sponsor     -       -       -       -       150,000       -       150,000  
Net loss     -       -       -       -       -       -       -  
Balance, September 30, 2025     -     $ -       5,300,000     $ 530     $ 174,470     $ -     $ 175,000  

 

(1) On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 units. The over-allotment option expired unexercised with respect to the remaining 1,550,000 Units on June 29, 2026, and 516,667 Class B ordinary shares held by the Sponsor were forfeited.

  

(2) Shares and associated amounts have been retroactively restated to reflect the surrender for no consideration of 1,916,666 Class B ordinary shares by the Sponsor on May 7, 2026, and the forfeiture of 516,667 Class B ordinary shares by the Sponsor on June 29, 2026.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

IRON DOME ACQUISITION I CORP.
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND FOR THE PERIOD FROM
SEPTEMBER 5, 2025 (INCEPTION) THROUGH SEPTEMBER 30, 2025

 

    For the
Nine Months
Ended
September 30,
2026
    For the
Period from
September 5,
2025
(Inception)
through
September 30,
2025
 
Cash Flows from Operating Activities:            
Net income   $ 1,716,907     $ -  
Adjustments to reconcile net income to net cash used in operating activities:                
Interest earned on cash held in Trust     (2,065,245 )     -  
Change in fair value of overallotment option     (212,823 )     -  
Operating costs paid by shareholder of the Sponsor in exchange for equity     7,500       -  
Changes in assets/liabilities:                
Prepaid expenses     (266,369 )     -  
Accrued expenses     233,340       -  
Accounts payable     1,700       -  
Net Cash Used In Operating Activities     (584,990 )     -  
                 
Cash Flows from Investing Activities:                
Cash deposited into Trust Account     (157,785,000 )     -  
Net Cash Used In Investing Activities     (157,785,000 )     -  
                 
Cash Flows from Financing Activities:                
Proceeds from issuance of Class A ordinary shares     157,000,000       -  
Proceeds from issuance of private placement warrants     2,750,000       -  
Repayment of sponsor note     (86,158 )     -  
Payment of offering costs     (644,679 )     -  
Net Cash Provided by Financing Activities     159,019,163       -  
                 
Net change in cash     649,173       -  
Cash at beginning of period     -       -  
Cash at end of period   $ 649,173     $ -  
                 
Supplemental Schedule of Non-Cash Financing Activities:                
IPO Advisor shares issued for offering costs   $ 2,000,000     $ -  
Issuance of Class B ordinary shares in exchange for a payment to a vendor   $ -     $ 25,000  
Offering cost services provided by shareholder of the Sponsor that were forgiven   $ 90,000     $ 150,000  
Offering costs included in accrued offering costs   $ -     $ 37,828  
Deferred underwriting commission included in non cash Initial Public Offering costs   $ 9,420,000     $ -  
Remeasurement of Class A ordinary shares to redemption value   $ 14,977,354     $ -  
Initial recognition of over-allotment liability     212,823       -  
Fair value of warrants issued as offering cost     1,422,185       -  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

IRON DOME ACQUISITION I CORP.
Notes to UNAUDITED Condensed Financial Statements

SEPTEMBER 30, 2026

 

NOTE 1 - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

 

Iron Dome Acquisition I Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on September 5, 2025. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

 

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, however, it intends to focus its search on businesses in the cybersecurity, defense technology, artificial intelligence and data infrastructure sectors, particularly companies with significant operations or management in Israel. The Company is an early-stage and emerging growth company; and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies.

 

As of September 30, 2026, the Company had not commenced any operations. All activity for the period from September 5, 2025 (inception) through September 30, 2026, relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

 

On May 18, 2026, the Company consummated its Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the Class A ordinary shares (as defined below) included in the Units offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds to the Company of $150,000,000 (the “Public Proceeds”). The Units had an initial redemption value of $10.05 per Unit.

 

Simultaneously with the closing of the Initial Public Offering, the Company completed a private sale of 2,750,000 warrants (“Private Placement Warrants”) at $1.00 per Private Placement Warrant, to Iron Dome Acquisition I Parent LLC (the “Sponsor”) for an aggregate purchase price of $2,750,000. Of this amount, $785,000, inclusive of the amount related to the over-allotment, was deposited into the Trust Account to fund the additional initial redemption value of $0.05 per Unit.

 

Transaction costs amounted to $12,633,304, consisting of a $250,000 cash underwriting fee, $9,000,000 in deferred underwriting fees (including a $4,500,000 variable deferred underwriting fee and a $4,500,000 fixed advisory fee), $2,000,000 fair value of IPO Advisors’ 200,000 shares, and $1,383,304 of other offering costs.

 

On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 units. The closing of the issuance and sale of additional units occurred on May 20, 2026, at a price of $10.00 per unit ($10.05 initial redemption value per unit) and generated total gross proceeds of $7,000,000. Transaction costs related to the exercise of the over-allotment option were $420,000, comprised of $210,000 each for the deferred underwriting fee and fixed advisory fee.

 

The over-allotment option expired on June 29, 2026 with 1,550,000 Units unexercised. The fair value of the unexercised over-allotment option was $212,823.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions, if any, and Permitted Withdrawals on the interest income earned on the funds held in the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Initial Public Offering, the Company deposited $10.05 per Unit sold in the Initial Public Offering, including a portion of the proceeds of the sale of the Private Placement Warrants, into a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

 

5

 

 

NOTE 1 - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (cont.)

 

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.05 per Public Share, plus any pro rata interest then in the Trust Account), net of taxes payable for the Company’s franchise and income taxes (“Permitted Withdrawals”). There will be no redemption rights upon the completion of a Business Combination with respect to the Private Placement Warrants. The Public Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

 

If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires a resolution be passed by a majority of the holders of the Class A ordinary shares, par value $0.0001 (the “Class A ordinary shares”) and the Class B ordinary shares, par value $0.0001 (the “Class B ordinary shares,” and together with the Class A ordinary shares, the “ordinary shares”) who, being entitled to do so, vote in person or by proxy at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Articles”), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and not to redeem any such shares in connection therewith. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting and, if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

 

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, the Articles provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

 

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholder’s rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment.

 

If the Company has not completed a Business Combination within 18 months from the closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to pay the Permitted Withdrawals, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

 

6

 

 

NOTE 1 - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (cont.)

 

The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for the Company’s initial Business Combination and redemptions could be reduced to less than $10.05 per Public Share. In such event, the Company may not be able to complete its initial Business Combination, and the Public Shareholders would receive such lesser amount per share in connection with any redemption of their Public Shares. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

 

Going Concern Considerations

 

As of September 30, 2026, the Company had cash of $649,173 and working capital of $913,842.

 

Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to provide the Company Working Capital Loans (as defined in Note 5).

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Presentation of Financial Statements – Going Concern,” management has determined that if the Company is unable to complete a Business Combination by November 18, 2027, the end of the Combination Period, the Company will cease all operations except for the purpose of liquidating. The mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited condensed financial statements are issued.

 

No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 18, 2027. These unaudited condensed financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

 

7

 

 

NOTE 1 - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (cont.)

 

Risks and Uncertainties

 

Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Specifically, the rising conflict between Russia and Ukraine, and the rising conflicts in the Middle East, and resulting market volatility could adversely affect the Company’s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the U.S. and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in annual financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The interim results for the three and nine months ended September 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026, or for any future periods.

 

The information included in this Form 10-Q should be read in conjunction with information included in the Company’s Form 8-K filed with the SEC on May 22, 2026, the audited financial statements and notes thereto included in the Company’s Registration Statement on Form S-1, and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, filed with the SEC on June 26, 2026 and August 14, 2026, respectively.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

8

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2026 and December 31, 2025.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation (“FDIC”) limit and cash held in the trust with a financial institution, which, at times, may exceed the Securities Investor Protection Corporation (“SIPC”) limit. As of September 30, 2026 and December 31, 2025, the cash held exceeded the FDIC limit by $399,173 and $0, respectively. As of September 30, 2026 and December 31, 2025, the cash held in the trust in excess of the SIPC limit was $159,600,245 and $0, respectively. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

Deferred Offering Costs

 

The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering” and Topic 5T - “Accounting for Expenses or Liabilities Paid by Principal Stockholder(s).”

 

Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering, which include professional and registration fees incurred. Deferred offering costs, together with the underwriting discounts and commissions, were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. As of September 30, 2026 and December 31, 2025, the Company had deferred offering costs of $0 and $695,255, respectively.

 

9

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

 

Net Income (Loss) per Ordinary Share

 

Net Income (Loss) per share is computed by dividing net Income (Loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Shares and associated accounts have been retroactively restated to reflect the forfeiture of 516,667 Class B ordinary shares by the Sponsor on June 29, 2026 upon expiration of the underwriter’s over-allotment option (see Note 5). The Company applies the two-class method in calculating net income (loss) per ordinary share, allocating income and losses between Class A ordinary shares subject to possible redemption and non-redeemable Class A and Class B ordinary shares as described below. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the 10,600,000 warrants (7,850,000 Public Warrants and 2,750,000 Private Placement Warrants) issued in connection with the Initial Public Offering and the Private Placement, because their exercise is contingent upon the occurrence of future events (the consummation of a Business Combination). As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. 

 

For the Three Months Ended September 30, 2026

 

    Redeemable     Non- redeemable  
Basic and diluted net income (loss) per ordinary share numerator:            
Interest income   $ 1,408,474     $ -  
Change in fair value of overallotment option     -       -  
Less: allocation of expenses     (237,559 )     (83,221 )
Total   $ 1,170,915     $ (83,221 )
                 
Basic and diluted net income (loss) per ordinary share denominator:                
Weighted-average shares outstanding     15,700,000       5,500,000  
Basic and diluted net income (loss) per ordinary share   $ 0.07     $ (0.02 )

 

10

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

For the Nine Months Ended September 30, 2026

 

    Redeemable     Non- redeemable  
Basic and diluted net income (loss) per ordinary share numerator:            
Interest income   $ 2,065,245     $ -  
Change in fair value of overallotment option     212,823       -  
Less: Allocation of expenses     (330,946 )     (230,215 )
Total   $ 1,947,122     $ (230,215 )
                 
Basic and diluted net income (loss) per ordinary share denominator:                
Weighted-average shares outstanding     7,761,172       5,398,901  
Basic and diluted net income (loss) per ordinary share   $ 0.25     $ (0.04 )

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature. See Note 10.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

 

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Cash held in trust is a Level 1 asset.

 

11

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the unaudited condensed balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the unaudited condensed balance sheet date.

 

Warrant Instruments

 

The Company accounts for the Public Warrants issued in connection with the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in FASB ASC 815, “Derivatives and Hedging.” Under ASC 815-40, the Public Warrants (as defined below) and the Private Placement Warrants meet the criteria for equity treatment and as such will be recorded in shareholder’s equity. If the Public Warrants and Private Placement Warrants no longer meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the unaudited condensed statements of operations.

 

Related Parties

 

Parties, which can be a corporation or individual, are considered to be related if either the Company or the other party have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or significant influence.

 

Class A Ordinary Shares Subject to Redemption

 

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies the Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity (deficit) section of the Company’s condensed balance sheets.

 

As of September 30, 2026, the Class A ordinary shares subject to redemption reflected in the condensed balance sheet are reconciled in the following table.

 

Gross Proceeds - Initial Public Offering   $ 150,000,000  
Less: Proceeds allocated to public warrants     (1,358,489 )
Less: Class A ordinary shares issuance costs     (12,350,169 )
Add: Accretion of carrying value to redemption value     14,458,658  
Class A ordinary shares subject to possible redemption as of May 18, 2026     150,750,000  
Gross Proceeds - partial exercise of overallotment option     7,000,000  
Less: Proceeds allocated to public warrants     (63,696 )
Less: Class A ordinary shares issuance costs     (420,000 )
Add: Accretion of carrying value to redemption value     1,175,467  
Class A ordinary shares subject to possible redemption as of June 30, 2026   $ 158,441,771  
Add: Remeasurement of carrying value to redemption value     1,408,474  
Class A ordinary shares subject to possible redemption as of September 30, 2026   $ 159,850,245  

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

12

 

 

NOTE 3 - INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 15,700,000 Units (including 700,000 Units from the underwriter’s partial exercise of the over-allotment option) at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per full share, subject to adjustment (see Note 8).

 

NOTE 4 - PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Company in a private placement sold 2,750,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant (the “Private Placement”). Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the sale of the Private Placement Warrants was added to the net proceeds from the Initial Public Offering (including the underwriter’s partial exercise of the over-allotment option) held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination, subject to certain exceptions.

 

$785,000 of the proceeds from the Private Placement was deposited into the Trust Account to fund the additional initial redemption value of $0.05 per Unit (resulting in an initial redemption value of $10.05 per Unit).

 

NOTE 5 - RELATED PARTIES

 

Founder Shares

 

On September 26, 2025, the Sponsor received 7,666,667 of the Company’s Class B ordinary shares (the “Founder Shares”) in exchange for a payment of $25,000 to a vendor.

 

On January 26, 2026, the Company issued 66,666 Class B ordinary shares to the Sponsor for no consideration, based on the expectation that the Founder Shares would represent 25% of the outstanding ordinary shares upon completion of the Initial Public Offering. On May 7, 2026, the Sponsor surrendered 1,916,666 Class B ordinary shares for no consideration. On June 29, 2026, upon expiration of the underwriter’s over-allotment option, 516,667 Class B ordinary shares held by the Sponsor were forfeited. Shares and associated accounts have been retroactively restated to reflect the issuance of 66,666 Class B ordinary shares, the surrender of 1,916,666 Class B ordinary shares, and the forfeiture of 516,667 Class B ordinary shares, resulting in 5,300,000 Class B ordinary shares issued and outstanding as of September 30, 2026 and December 31, 2025.

 

Up to 750,000 Founder Shares held by the Sponsor were subject to forfeiture by the holders thereof depending on the extent to which the underwriter’s over-allotment option was exercised, so that the number of Founder Shares would collectively represent 25% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On May 19, 2026, the underwriter partially exercised the over-allotment option and purchased an additional 700,000 Units at the public offering price, which closed on May 20, 2026. On June 29, 2026, upon expiration of the underwriter’s over-allotment option, 516,667 Class B ordinary shares held by the Sponsor were forfeited. Following such forfeiture, the Sponsor holds 5,300,000 Class B ordinary shares

 

On December 2, 2025, December 10, 2025, and January 21, 2026, the Sponsor completed three separate transfers of Class B Ordinary Shares to the Company’s director nominees, transferring 200,000 Class B Ordinary Shares to each of Waldo Holdings 8 on behalf of Eyal Waldman, David DeWalt, and Paul Hodermarsky (600,000 Class B Ordinary Shares in the aggregate) for no cash consideration as compensation for their services to be provided as public company directors. The fair value of the shares transferred was $1,260,000. The transferred shares are subject to the lock-up provisions. As such, the Company will not recognize any stock-based compensation expense until the completion of the initial Business Combination is considered probable.

 

13

 

 

NOTE 5 - RELATED PARTIES (cont.)

 

The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell 90% of the Founder Shares until the earlier to occur of: (A) six months after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property; provided that, for the avoidance of doubt, 10% of the Founder Shares shall not be subject to such restrictions.

 

General and Administrative Services

 

The Company entered into an agreement, commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor or an affiliate thereof a monthly fee of $25,000 for office space, utilities and secretarial and administrative support. For the three and nine months ended September 30, 2026, the Company incurred expenses related to the agreement of $75,000 and $125,000, respectively. As of September 30, 2026, no amounts were unpaid.

 

Unsecured Promissory Note

 

The Sponsor agreed to loan the Company up to $300,000 under an unsecured promissory note to be used for a portion of the expenses of the Initial Public Offering. This loan is non-interest bearing, unsecured and is due upon the earlier of January 30, 2026, the closing of the Initial Public Offering, or an earlier event of default. On May 8, 2026 the note was extended to December 31, 2026. As of September 30, 2026 and December 31, 2025, there was $0 and $86,158, respectively, outstanding under such promissory note. The note was fully repaid in connection with the Initial Public Offering and is no longer available to the Company.

 

Working Capital Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted into Class A ordinary shares of the post-business combination entity at a price of $10.00 per share at the option of the Sponsor. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2026 and December 31, 2025, there was no amount outstanding under the Working Capital Loans.

 

Contributed Services from a Related Party

 

An officer and director of the Company, who is an indirect member of the Sponsor, has provided legal services to the Company for no cost. The Company has estimated the value of the services to be $97,500 for the nine months ended September 30, 2026 (of which $7,500 related to the three months ended September 30, 2026) and $375,000 for the period from September 5, 2025 (inception) through December 31, 2025. The Company has evaluated these services in accordance with ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering” and Topic 5T - “Accounting for Expenses or Liabilities Paid by Principal Stockholder(s).” and recorded offering costs of $90,000 (charged against the instruments issued in the Initial Public Offering upon its consummation) and formation and operating expenses of $7,500 for the nine months ended September 30, 2026, and deferred offering costs of $375,000 as of December 31, 2025, with corresponding increases to additional paid-in capital of $97,500 and $375,000, respectively.

 

14

 

 

NOTE 6 - COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Warrants and Class A ordinary shares that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement entered into on May 14, 2026, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriter a 45-day option from the date of the prospectus to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On May 19, 2026, the underwriter partially exercised the over-allotment option and purchased an additional 700,000 Units at the public offering price, which closed on May 20, 2026, generating gross proceeds of $7,000,000. On June 29, 2026, the over-allotment option expired unexercised with respect to the remaining 1,550,000 Units, and 516,667 Class B ordinary shares held by the Sponsor were forfeited.

 

The underwriter received a fixed cash underwriting discount of $250,000 in the aggregate, which was paid upon the closing of the Initial Public Offering.

 

The underwriter is entitled to a deferred underwriting commission of 3% of the gross proceeds of the Initial Public Offering ($4,500,000 in the aggregate or $5,175,000 if the underwriter’s over-allotment option is exercised in full), payable upon completion of the Business Combination. The deferred underwriting commission is subject to adjustment based on redemptions, if any, of Class A ordinary shares. As of September 30, 2026, $4,710,000 is included in deferred underwriting commission.

 

Additionally, the underwriter is entitled to an additional 3% of the gross proceeds of the Initial Public Offering ($4,500,000 in the aggregate or $5,175,000 if the underwriter’s over-allotment option is exercised in full), for advisory fees payable upon completion of the Business Combination. These fees are earned upon the closing of the Initial Public Offering, regardless of future activity. As such, the Company has concluded that these represent underwriting and not advisory fees. As of September 30, 2026, $4,710,000 is included in deferred underwriting commission, for a total of $9,420,000 of deferred underwriting commission and advisory fees presented on the condensed unaudited balance sheet.

 

IPO Advisors

 

D. Boral Capital LLC (“D. Boral”) and ARC Group Securities LLC (“ARC Securities” and together with D. Boral, the “IPO Advisors”) provided consulting and advisory services to the Company in connection with the Initial Public Offering. The IPO Advisors received an aggregate of 200,000 Class A ordinary shares (fair value of $2,000,000) at the closing of the Initial Public Offering as their compensation for such services. These fees were accounted for as offering costs.

 

Service Providers Fees

 

Certain service providers have agreed to defer the payment of certain fees and expenses until the completion of the initial Business Combination. The amount as of September 30, 2026 was $690,136, and is presented as non-current accrued offering costs.

 

15

 

 

NOTE 7 - SHAREHOLDERS’ EQUITY (DEFICIT)

 

Preferred Shares - The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

 

Class A Ordinary Shares - The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of September 30, 2026 and December 31, 2025, respectively, there were 200,000 and 0 Class A ordinary shares issued and outstanding, excluding 15,700,000 Class A ordinary shares subject to possible redemption.

 

Class B Ordinary Shares - The Company is authorized to issue 15,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of September 30, 2026 and December 31, 2025, there were 5,300,000 Class B ordinary shares issued and outstanding. On May 19, 2026, the underwriter partially exercised the over-allotment option and purchased 700,000 Units, which closed on May 20, 2026. The over-allotment option expired unexercised with respect to the remaining 1,550,000 Units on June 29, 2026, and 516,667 Class B ordinary shares held by the Sponsor were forfeited. Following such forfeiture, the Sponsor holds 5,300,000 Class B ordinary shares.

 

Only holders of the Class B ordinary shares will have the right to vote on the appointment of directors prior to the Business Combination. Holders of ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as otherwise required by law. In connection with the Company’s initial Business Combination, it may enter into a shareholders agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of the Initial Public Offering.

 

The Founder Shares are designated as Class B ordinary shares and will automatically convert at a ratio of one-for-one into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the Company’s initial Business Combination.

 

NOTE 8 - WARRANTS

 

There were 10,600,000 warrants (7,850,000 Public Warrants, including 350,000 Public Warrants issued upon the partial exercise of the over-allotment option, and 2,750,000 Private Placement Warrants) and 0 warrants outstanding as of September 30, 2026 and December 31, 2025, respectively. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

The Company will not be obligated to deliver any Class A ordinary share pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

 

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. Notwithstanding the above, if the Class A ordinary share is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

16

 

 

NOTE 8 - WARRANTS (cont.)

 

Redemption of Warrants When the Price per Class A ordinary share Equals or Exceeds $18.00 - Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

 

● in whole and not in part;

 

● at a price of $0.01 per Public Warrant;

 

● upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and

 

● if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganization, recapitalizations and the like) for any 10 trading days within a 20-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.

 

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

If the Company calls the warrants for redemption as described in this paragraph, its management will have the option to require any holder that wishes to exercise their warrant following the notice of redemption to do so on a cashless basis. In the case of such a cashless exercise, each holder would pay the exercise price by surrendering the Public Warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” less the exercise price of the warrants by (y) the fair market value. The “fair market value” as used in the preceding sentence shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of redemption is sent to the holders of the public warrants. If its management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of Class A ordinary shares to be received upon exercise of the warrants, including the “fair market value” in such case.

 

The Company has established the $18.00 per share (as adjusted) redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the public warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each Public Warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price, as well as the $11.50 Public Warrant exercise price after the redemption notice is issued.

 

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by its board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of its initial Business Combination on the date of the completion of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 day trading period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

 

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

 

NOTE 9 - SEGMENT INFORMATION

 

ASC Topic 280, Segment Reporting, establishes standards for companies to report, in their unaudited condensed financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

 

The Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reporting segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statements of operations as net income or loss. The measure of segment assets is reported on the unaudited condensed balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets.

 

17

 

 

NOTE 9 - SEGMENT INFORMATION (cont.)

 

Formation and operating expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews formation and operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation and operating expenses, as reported on the unaudited condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

 

All other segment items included in net income are reported on the unaudited condensed statements of operations and described within their respective disclosures.

 

For the three and nine months ended September 30, 2026, significant segment expenses consisted of formation and operating expenses of $320,780 and $561,161, respectively (including administrative services fees to the Sponsor of $75,000 and $125,000, respectively), and other segment items consisted of income earned on the Trust Account of $1,408,474 and $2,065,245, respectively, and, for the nine months ended September 30, 2026, the change in fair value of the over-allotment option of $212,823. Segment assets were $160,765,787 as of September 30, 2026. There was no segment activity for the period from September 5, 2025 (inception) through September 30, 2025.

 

NOTE 10 - FAIR VALUE MEASUREMENTS

 

The fair value of the Public and Private Warrants is measured under Level 3 in the fair value hierarchy as of May 18, 2026. The fair value of Public Warrants was determined using Black-Scholes Model.

 

The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance.

 

The market assumptions used to determine fair value as follows:

 

    As of
May 18,
2026
 
Term     5 years  
Dividends   $ 0  
Risk Free Rate     4.27 %
Probability of an Initial Business Combination     21.00 %
Volatility     5.00 %

 

The expected term of the warrants is based on the actual term of the warrants in the event of a successful business combination. The probability of an initial business combination is based on historical data from SPACs that have successfully completed an initial public offering and then gone on to complete a business combination. The risk-free rate is the treasury rate for a treasury security with a similar term. The volatility is based on historical volatility of comparable publicly traded SPACs.

 

The fair value of the over-allotment option is measured under Level 3 in the fair value hierarchy as of May 18, 2026. The fair value of over-allotment was determined using Black-Scholes Model.

 

The over-allotment has been classified as a liability and will be subject to remeasurement each reporting period.

 

The assumptions used to determine fair value of the underwriter’s over-allotment option are as follows:

 

    As of
May 18,
2026
 
Term     45 days  
Dividend rate     0 %
Risk Free Rate     3.68 %
Volatility     5.00 %

 

The expected term is the number of days the underwriter had to exercise the over-allotment option per the terms of the underwriting agreement. The risk-free rate is the treasury rate for a treasury security with a similar term. The volatility is based on historical volatility of comparable publicly traded SPACs.

 

18

 

 

NOTE 11 - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

In connection with the preparation of the Company’s unaudited condensed financial statements as of and for the three and nine months ended September 30, 2026, management identified an error in the initial fair value measurement of the Public Warrants issued in connection with the Initial Public Offering, which affected the Company’s previously issued unaudited condensed financial statements as of and for the three and six months ended June 30, 2026, included in the Company’s Quarterly Report on Form 10-Q. The Public Warrants previously disclosed fair value was $3,164,821. The revised fair value is $1,422,185.

 

In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” management evaluated the error and determined that the related impact was not material to the previously issued financial statements. The Company has revised the previously reported amounts presented in the accompanying unaudited condensed statements of changes in shareholders’ equity (deficit). The error had no impact on the Company’s total assets, total liabilities, Class A ordinary shares subject to possible redemption, total shareholders’ deficit, net income or cash flows.

 

NOTE 12 - SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date through November 16, 2026, the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

19

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Iron Dome Acquisition I Corp. References to our “management” or our “management team” refer to our officers and directors and references to the “Sponsor” refer to Iron Dome Acquisition I Parent LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company incorporated as a Cayman Islands exempted company on September 5, 2025 for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Quarterly Report as our initial business combination. We intend to effectuate our initial business combination using cash from the proceeds of the initial public offering (the “Initial Public Offering”) and the sale of the private placement warrants (the “Private Placement”) and the proceeds of the sale of our securities in connection with our initial business combination (pursuant to any forward purchase agreements, backstop or similar agreements we may enter into following the consummation of the Initial Public Offering or otherwise), our shares, debt or a combination of cash, equity and debt.

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from September 5, 2025 (inception) through September 30, 2026 were organizational activities, those necessary to prepare for the Initial Public Offering and, since the closing of the Initial Public Offering, identifying and evaluating prospective targets for a Business Combination. Following the Initial Public Offering, we will continue not to generate any operating revenues until after completion of our initial business combination. We will continue to generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and the Private Placement held in the Trust Account. After the Initial Public Offering, we will continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 

For the three months ended September 30, 2026, we had net income of $1,087,694, which consists of $1,408,474 of income earned on cash held in Trust, partially offset by formation and operating expenses of $320,780. For the nine months ended September 30, 2026, we had net income of $1,716,907, which consists of $2,065,245 of income earned on cash held in Trust and change in fair value of overallotment option of $212,823, partially offset by formation and operating expenses of $561,161. For the period from September 5, 2025 (inception) through September 30, 2025, we had no net income or loss.

 

20

 

 

Liquidity and Capital Resources

 

As of September 30, 2026, we had cash of $649,173 held outside the Trust Account and working capital of $913,842. Until the consummation of the Initial Public Offering, our only sources of liquidity were an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and a loan from the Sponsor, of up to $300,000 under an unsecured, non-interest bearing promissory note, which was repaid on May 18, 2026.

 

On May 18, 2026, we consummated the Initial Public Offering of 15,000,000 Units (the “Public Units” and, with respect to the Class A ordinary shares and public warrants included in the Public Units, the “Public Shares”, and “Public Warrants”, respectively). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $150,000,000.

 

Simultaneously with the closing of the Initial Public Offering, we completed the private sale of 2,750,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $2,750,000 (the “Private Placement”). The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon their exercise may not be transferred, assigned or sold until 30 days after the completion of a Business Combination, subject to limited exceptions.

 

On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000, less deferred underwriting commission of $420,000.

 

Following the closing of the Initial Public Offering, the Private Placement and the Over-Allotment, a total of $157,785,000 was placed in the Trust Account. We incurred $12,633,304, consisting of $250,000 cash underwriting fee, $9,000,000 deferred underwriter fee, $2,000,000 fair value of 200,000 shares of Class A ordinary shares issued to our advisors in connection with the Initial Public Offering, and $1,383,304 of other offering costs. In connection with the partial exercise of the over-allotment option, we incurred an additional $420,000 of deferred underwriting commissions and deferred advisory fees, for total transaction costs of $13,053,304.

 

We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (which interest shall be net of any franchise and income taxes payable and excluding deferred underwriting commissions), to complete our initial Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial Business Combination.

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted into Class A ordinary shares of the post-business combination entity at a price of $10.00 per share at the option of the Sponsor. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2026, there was no amount outstanding under the Working Capital Loans.

 

For the nine months ended September 30, 2026, cash used in operating activities was $584,990. Net income of $1,716,907 was adjusted for income earned on cash held in the Trust Account of $2,065,245, the non-cash change in fair value of the over-allotment option of $212,823 and contributed services of $7,500, and changes in operating assets and liabilities used $31,329 of cash.

 

For the nine months ended September 30, 2026 cash used in investing activities was $157,785,000, which consisted of the funds deposited into the Trust.

 

For the nine months ended September 30, 2026 cash provided by financing activities was $159,019,163, which consisted of the proceeds from the Initial Public Offering and private placement, partially offset by the payment of offering costs and the repayment of the promissory note.

 

21

 

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Presentation of Financial Statements- Going Concern,” the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. If the Company is unable to complete a Business Combination by November 18, 2027, the end of the Combination Period, the Company will cease all operations except for the purpose of liquidating. Management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 18, 2027.

 

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations

 

As of September 30, 2026, we did not have any off-balance sheet arrangements as defined in Item 303 of Regulation S-K. Our commitments and contractual obligations consist of the deferred underwriting commission and deferred advisory fee payable to the underwriter upon the consummation of a Business Combination (aggregating $9,420,000), fees and expenses of certain service providers that have agreed to defer payment until the consummation of a Business Combination ($690,136 as of September 30, 2026), and the administrative services agreement with the Sponsor, under which we pay $25,000 per month, each as described below and in Notes 5 and 6 to the unaudited condensed financial statements.

 

The Company granted the underwriter a 45-day option from the date of the prospectus to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units. The closing of the Over-Allotment Option Units occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.

 

The underwriter was entitled to a cash underwriting discount of $250,000, which was paid upon the closing of the Initial Public Offering.

 

The underwriter is entitled to a deferred underwriting commission of 3% of the gross proceeds of the Initial Public Offering ($4,500,000 in the aggregate or $5,175,000 if the underwriter’s over-allotment option is exercised in full), payable upon completion of the Business Combination. The deferred underwriting commission is subject to adjustment based on redemptions, if any, of Class A ordinary shares. As of September 30, 2026, $4,710,000 is included in deferred underwriting commission.

 

Additionally, the underwriter is entitled to an additional 3% of the gross proceeds of the Initial Public Offering ($4,500,000 in the aggregate or $5,175,000 if the underwriter’s over-allotment option is exercised in full), for advisory fees payable upon completion of the Business Combination. As of September 30, 2026, $4,710,000 is included in deferred underwriting commission, for a total of $9,420,000 of deferred underwriting commission and advisory fees presented on the condensed balance sheet. These fees are earned upon the closing of the Initial Public Offering, regardless of future activity. As such, the Company has concluded that these represent underwriting and not advisory fees.

 

Critical Accounting Estimates

 

The preparation of the unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. We consider the initial fair value measurements of the Public Warrants and the over-allotment option, which were determined as of May 18, 2026 using Level 3 inputs, including the probability of consummating a Business Combination and expected volatility (see Note 10 to the unaudited condensed financial statements), to be our critical accounting estimates. Because the Public Warrants are classified in equity and the over-allotment option expired on June 29, 2026, these estimates are not remeasured and changes in the underlying assumptions would not affect our results of operations for the periods presented.

 

22

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures

 

Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, due to the material weakness in our internal control over financial reporting described below, our disclosure controls and procedures were not effective as of September 30, 2026.

 

Material Weakness

 

In connection with the preparation of our unaudited condensed financial statements for the quarter ended September 30, 2026, management identified a material weakness in our internal control over financial reporting related to the accounting for complex financial instruments, specifically the initial fair value measurement of the Public Warrants issued in connection with the Initial Public Offering

 

In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited condensed financial statements were prepared in accordance with US GAAP. Accordingly, management believes that the unaudited condensed financial statements included in this Quarterly Report present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented.

 

We plan to remediate the material weakness by enhancing our processes to identify and appropriately apply applicable accounting requirements to complex financial instruments, including enhanced review of third-party valuation reports and the significant inputs and assumptions used therein, enhanced access to accounting literature and research materials, and increased communication among our personnel and the third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

 

23

 

 

Internal Control Over Financial Reporting

 

We are not currently required to certify an effective system of internal controls as defined by Section 404 of the Sarbanes-Oxley Act. We will be required to comply with the internal control requirements of the Sarbanes-Oxley Act for the fiscal year ending December 31, 2027. Only in the event that we are deemed to be a large accelerated filer or an accelerated filer and no longer an emerging growth company would we be required to comply with the independent registered public accounting firm attestation requirement.

 

Further, for as long as we remain an emerging growth company as defined in the JOBS Act, we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirement.

 

As of September 30, 2026, we have not completed an assessment, nor has our independent registered public accounting firm tested our systems, of internal controls. We expect to assess the internal controls of our target business or businesses prior to the completion of our initial business combination and, if necessary, to implement and test additional controls as we may determine are necessary in order to state that we maintain an effective system of internal controls. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy of internal controls. Many small and mid-sized target businesses we may consider for our initial business combination may have internal controls that need improvement in areas such as:

 

● staffing for financial, accounting and external reporting areas, including segregation of duties;

 

● reconciliation of accounts;

 

● proper recording of expenses and liabilities in the period to which they relate;

 

● evidence of internal review and approval of accounting transactions;

 

● documentation of processes, assumptions and conclusions underlying significant estimates; and

 

● documentation of accounting policies and procedures.

 

Because it will take time, management involvement and perhaps outside resources to determine what internal control improvements are necessary for us to meet regulatory requirements and market expectations for our operation of a target business, we may incur significant expenses in meeting our public reporting responsibilities, particularly in the areas of designing, enhancing, or remediating internal and disclosure controls. Doing so effectively may also take longer than we expect, thus increasing our exposure to financial fraud or erroneous financial reporting. Once our management’s report on internal controls is complete, we will retain our independent public accounting firm to audit and render an opinion on such report when required by Section 404 of the Sarbanes-Oxley Act. The independent public accounting firm may identify additional issues concerning a target business’s internal controls while performing their audit of internal control over financial reporting.

 

Changes in Internal Control over Financial Reporting

 

Other than as described above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

24

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors in our Registration Statement on Form S-1 and our prospectus dated May 14, 2026. Except as set forth below, there have been no material changes to those risk factors.

 

We have identified a material weakness in our internal control over financial reporting as of September 30, 2026. If we are unable to remediate this material weakness, or if we identify additional material weaknesses in the future or otherwise fail to maintain effective internal control over financial reporting, we may not be able to report our financial results accurately or in a timely manner, which may adversely affect investor confidence in us, the value of our securities and our ability to complete an initial business combination.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. In connection with the preparation of our unaudited condensed financial statements as of and for the three and nine months ended September 30, 2026, management identified an error in the initial fair value measurement of the Public Warrants issued in connection with our Initial Public Offering, which affected our previously issued unaudited condensed financial statements as of and for the three and six months ended June 30, 2026. Although we determined that the error was not material to those previously issued financial statements, our management concluded that the error resulted from a material weakness in our internal control over financial reporting related to the accounting for complex financial instruments. As a result, our management concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

 

We plan to remediate this material weakness by enhancing our processes to identify and appropriately apply applicable accounting requirements to complex financial instruments, including enhanced review of third-party valuation reports and the significant inputs and assumptions used therein, enhanced access to accounting literature and research materials, and increased communication among our personnel and the third-party professionals with whom we consult regarding complex accounting applications. However, there can be no assurance that these measures will be sufficient to remediate the material weakness or to prevent future material weaknesses or control deficiencies. As a blank check company with limited personnel and no operations, we rely heavily on third-party service providers for the accounting for complex financial instruments, which may limit our ability to detect errors in a timely manner.

 

If we are unable to remediate the material weakness in a timely manner, or if we identify additional material weaknesses, we may be unable to accurately or timely report our financial condition or results of operations. This could lead to further revisions or restatements of our financial statements, cause us to fail to meet our reporting obligations under the Exchange Act, result in a loss of investor confidence in the accuracy and completeness of our financial reports, cause the market price of our securities to decline, or subject us to investigation or sanctions by the SEC, Nasdaq or other regulatory authorities. In addition, we may face litigation or other disputes, which may include, among others, claims invoking federal and state securities laws, contractual claims or other claims arising from the material weakness or any revision or restatement of our financial statements. As of the date of this Quarterly Report, we have no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On May 18, 2026, simultaneously with the closing of the Initial Public Offering, we completed the private sale of 2,750,000 Private Placement Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds of $2,750,000, and we issued an aggregate of 200,000 Class A ordinary shares to the IPO Advisors as compensation for services provided in connection with the Initial Public Offering. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, as previously reported in our Current Report on Form 8-K filed with the SEC on May 22, 2026. Other than the foregoing, there were no unregistered sales of equity securities during the three and nine months ended September 30, 2026.

 

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

25

 

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

During the three months ended September 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

  

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.

 

** These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

26

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Iron Dome Acquisition I Corp.
     
Date: November 16, 2026 By: /s/ Tom Y. Livne
  Name: Tom Y. Livne
  Title: Chief Executive Officer and Director
    (Principal Executive Officer)
     
Date: November 16, 2026 By: /s/ Matthew J. Norden
  Name: Matthew J. Norden
  Title: Chief Financial Officer and Director
    (Principal Financial and Accounting Officer)

 

27

 

Keep reading